Pharmaceuticals News and Research

RSS

Erlotinib increases survival in patients with advanced non-small cell lung cancer

An international clinical study led by Canadian researchers has demonstrated that a drug called erlotinib increases survival in patients with advanced non-small cell lung cancer who typically have no other treatment options.

13 Jul 2005

Keap1 protein - a promising new target for drugs to fight many different kinds of cancer

Researchers at the University of Illinois at Chicago are unraveling the biochemical mechanism by which functional foods combat cancer.

11 Jul 2005

New treatment for rosacea

Galderma Laboratories has announced FDA approval of a new product for the topical treatment of the inflammatory lesions of rosacea. MetroGel (metronidazole) Topical Gel, 1% will be available by prescription July 29, 2005. The new medication incorporates a higher concentration of metronidazole in a new, technologically advanced vehicle.

6 Jul 2005

Drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder

The condition (bipolar I and II) affects approximately 8 million Americans, who have relied on a combination of drugs to manage their symptoms, and who remain at high risk of committing suicide because of the difficulty in treating the disorder.

6 Jul 2005

NitroMed have launched BiDil for the treatment of heart failure in black patients

NitroMed, Inc. announced today that BiDil® (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black patients as an adjunct to current standard therapies.

4 Jul 2005

RxKinetix receives grant to develop thermostable vaccines with improved stability at non-refrigerated temperatures

RxKinetix Inc., a specialty pharmaceutical company has received a grant offer from the prestigious Grand Challenges in Global Health initiative. The grant will be used to develop thermostable vaccines with improved stability at non-refrigerated temperatures for use in the world's poorest countries.

30 Jun 2005

Report highlights importance of research into diseases in developing countries

Better drugs and vaccines are needed to fight HIV/AIDS, tuberculosis (TB), malaria and other tropical diseases. Pharmaceutical research has typically focussed on developing drugs, vaccines and other interventions for diseases prevalent in developed countries, where people can afford to buy treatments; it has tended to overlook those disorders that predominantly affect developing countries.

30 Jun 2005

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

30 Jun 2005

Changes in economy and healthcare accompany Poland’s accession to the European Union

The European Union (EU) is in a state of flux following the recent accession of several Central and Eastern European countries. Their membership has further complicated the already complex economic, social and cultural dynamics at work within the EU.

28 Jun 2005

Vaccine against Lassa fever works in monkeys

Scientists say that a genetically engineered virus may possibly offer the first effective vaccine against Lassa fever.

28 Jun 2005

Canada about to ban bulk sales of drugs to U.S.

According to some press reports Canada is about to announce a ban on bulk sales of drugs to the United States as a way of reining in Internet pharmacies that sell cheap medicine to Americans.

28 Jun 2005

Tricirbine may help fight cancers

H. Lee Moffitt Cancer Center & Research Institute, working in partnership with the University of South Florida (USF), has discovered a new use for an old, previously discredited anti-cancer drug that could add another weapon in the arsenal against several cancers, including tumors of the breast, ovary, colon, skin and prostate.

27 Jun 2005

Insulin resistance drug with anti-inflammatory effects reduces risk factors

A drug, which reduces insulin resistance and also may have anti-inflammatory and other effects on blood vessels, lowered cardiovascular risk factors in patients with diabetes more than another diabetes medicine, even though both drugs improved blood sugar control equally, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.

21 Jun 2005

Australian community-based intervention program to successfully reduce antibiotics use for colds and flu

The South Australian Health Department is leading a community-based intervention program to successfully reduce antibiotics use for colds and flu.

21 Jun 2005

WHO says AIDS fight will only be won with generic drugs

According to the World Health Organisation (WHO) the key to AIDS treatment in the developing world is generic drugs, but the target of 3 million people on therapy by the end of 2005 may now be unattainable.

21 Jun 2005

Canada first country to approve cannabis based painkiller

Canada has become the first country to approve a cannabis based painkiller for multiple sclerosis (MS) patients.

21 Jun 2005

CSIRO hyperspectral imaging software can be used by pharmaceutical companies for production line quality assurance

New CSIRO imaging software means consumers could be confident their tablets contain exactly what their packaging says.

21 Jun 2005

Software that automatically assesses a drug's effect on nerve cells

Potential new drugs for neurological disorders like Parkinson's are being screened faster thanks to world-leading CSIRO software that automatically assesses a drug's effect on nerve cells.

21 Jun 2005

New cardiovascular drug derived from Dan Shen (Saliva miltiorrhiza)

Through a large number of clinical trials over the past 3 years, researchers from the CAS Shanghai Institute of Materia Medica (SIMM) have developed a new cardiovascular drug with a definite effective component extracted from Dan Shen (Saliva miltiorrhiza), a medicinal herb widely used in China.

21 Jun 2005

FDA severely limits access to cancer drug Iressa

After Food and Drug Administration (FDA) officials agreed with studies showing lung cancer drug, Iressa, did not help patients live longer, drug company AstraZeneca said it would severely limit access to its drug.

20 Jun 2005

Pharmaceuticals News and Research

Erlotinib increases survival in patients with advanced non-small cell lung cancer

Keap1 protein - a promising new target for drugs to fight many different kinds of cancer

New treatment for rosacea

Drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder

NitroMed have launched BiDil for the treatment of heart failure in black patients

RxKinetix receives grant to develop thermostable vaccines with improved stability at non-refrigerated temperatures

Report highlights importance of research into diseases in developing countries

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Changes in economy and healthcare accompany Poland’s accession to the European Union

Vaccine against Lassa fever works in monkeys

Canada about to ban bulk sales of drugs to U.S.

Tricirbine may help fight cancers

Insulin resistance drug with anti-inflammatory effects reduces risk factors

Australian community-based intervention program to successfully reduce antibiotics use for colds and flu

WHO says AIDS fight will only be won with generic drugs

Canada first country to approve cannabis based painkiller

CSIRO hyperspectral imaging software can be used by pharmaceutical companies for production line quality assurance

Software that automatically assesses a drug's effect on nerve cells

New cardiovascular drug derived from Dan Shen (Saliva miltiorrhiza)

FDA severely limits access to cancer drug Iressa

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News